PetIQ Past Earnings Performance
Past criteria checks 2/6
PetIQ's earnings have been declining at an average annual rate of -8%, while the Healthcare industry saw earnings growing at 10.4% annually. Revenues have been growing at an average rate of 11.8% per year. PetIQ's return on equity is 1.1%, and it has net margins of 0.2%.
Key information
-8.0%
Earnings growth rate
-5.0%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 11.8% |
| Return on equity | 1.1% |
| Net Margin | 0.2% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How PetIQ makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,102 | 2 | 190 | 1 |
| 30 Sep 23 | 1,066 | 13 | 186 | 2 |
| 30 Jun 23 | 999 | -37 | 177 | 2 |
| 31 Mar 23 | 936 | -42 | 171 | 2 |
| 31 Dec 22 | 922 | -48 | 174 | 2 |
| 30 Sep 22 | 934 | -55 | 173 | 8 |
| 30 Jun 22 | 935 | -14 | 170 | 8 |
| 31 Mar 22 | 954 | -15 | 164 | 8 |
| 31 Dec 21 | 933 | -16 | 158 | 8 |
| 30 Sep 21 | 900 | -11 | 136 | 0 |
| 30 Jun 21 | 852 | -73 | 138 | 0 |
| 31 Mar 21 | 848 | -79 | 122 | 1 |
| 31 Dec 20 | 780 | -83 | 116 | 2 |
| 30 Sep 20 | 770 | -85 | 121 | 3 |
| 30 Jun 20 | 794 | -20 | 102 | 3 |
| 31 Mar 20 | 748 | -15 | 95 | 2 |
| 31 Dec 19 | 709 | -11 | 91 | 1 |
| 30 Sep 19 | 666 | -4 | 84 | 0 |
| 30 Jun 19 | 611 | 4 | 75 | 0 |
| 31 Mar 19 | 562 | 3 | 69 | 0 |
| 31 Dec 18 | 529 | -1 | 67 | 0 |
| 30 Sep 18 | 470 | -1 | 60 | 0 |
| 30 Jun 18 | 399 | -3 | 53 | 0 |
| 31 Mar 18 | 315 | -6 | 49 | 0 |
| 31 Dec 17 | 267 | -3 | 37 | 1 |
| 30 Sep 17 | 260 | 0 | 34 | 0 |
| 30 Jun 17 | 241 | 0 | 32 | 0 |
| 31 Mar 17 | 215 | -2 | 29 | 0 |
| 31 Dec 16 | 200 | 0 | 28 | 0 |
| 31 Mar 16 | 202 | -5 | 33 | 0 |
| 31 Dec 15 | 206 | 0 | 35 | 0 |
| 31 Dec 14 | 161 | -11 | 29 | 1 |
Quality Earnings: 39L has a large one-off loss of $17.0M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 39L became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 39L has become profitable over the past 5 years, growing earnings by -8% per year.
Accelerating Growth: 39L has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 39L has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-2.5%).
Return on Equity
High ROE: 39L's Return on Equity (1.1%) is considered low.